Diverse data inputs, proven to be prognostic for kidney disease progression, specifically, based on multiple, third-party, clinical studies

• Real-time, patient blood draw
• 3 proprietary, blood-based biomarker concentrations (TNFR-1, TNFR-2, KIM-1), each robustly validated by multiple third-party studies
• Inclusion of clinical factors, derived from patients’ Electronic Health Records, that add to prognostic accuracy of kidneyintelX.dkd